Abstract:Following injury to the adult mammalian central nervous system, regenerative growth of severed axons is very limited. The lack of neuronal repair is often associated with significant functional deficits, and depending on the severity of injury, may result in permanent paralysis distal to the site of injury. A detailed understanding of the molecular mechanisms that limit neuronal growth in the injured spinal cord is an important step toward the development of specific strategies aimed at restoring functional connectivity lost as a consequence of injury. While rapid progress is being made in defining the molecular identity of CNS growth inhibitory constituents, comparatively little is known about their receptors and downstream signaling mechanisms. Emerging new evidence suggests that the mechanisms for myelin inhibition are likely to be complex, involving multiple and distinct receptor systems that may operate in a redundant manner. Furthermore, the relative contribution of a specific ligand-receptor system to bring about growth inhibition may greatly vary among different neuronal cell types. Myelin-associated glycoprotein (MAG), for example, employs different mechanisms to inhibit neurite outgrowth of cerebellar, sensory, and retinal ganglion neurons in vitro. Nogo-A harbors distinct growth inhibitory regions, which employ different signaling mechanisms. The Nogo-66 receptor 1 (NgR1), a shared ligand binding component in a receptor complex for Nogo-66, MAG, and OMgp, participates in neuronal growth cone collapse to acutely presented myelin inhibitors, but is dispensable for longitudinal neurite outgrowth inhibition on substrate-bound Nogo-66, MAG, OMgp, or crude CNS myelin in vitro. Consistent with the idea of cell-type specific mechanisms for myelin inhibition, different types of CNS neurons possess very different regenerative capacities and respond differently to experimental treatment strategies in vivo. We speculate that differences in regenerative axonal growth among different fiber systems are a reflection of their intrinsic ability to elongate axons and their distinct cell surface receptor profiles to respond to the growth inhibitory extracellular milieu. The existence of cell type specific mechanisms to impair regenerative axonal growth in the CNS may have important implications for the development of treatment strategies. Depending on the fiber tract injured, different ligand-receptor systems may need to be targeted in order to elicit robust and long-distance regenerative axonal growth.

The Initial Myelination in the Central Nervous System

Disruption of Nectin-Like 1 Cell Adhesion Molecule Leads to Delayed Axonal Myelination in the CNS

Oligodendrocytes: Myelination and Axonal Support.

Robust Myelination of Regenerated Axons Induced by Combined Manipulations of GPR17 and Microglia

Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration

Oligodendrocytes: Myelination, Plasticity, and Axonal Support

Coordinated Regulation of Myelination by Growth Factor and Amino-acid Signaling Pathways

Recent Advance in Oligodendrocyte Differentiation, Development and Myelin Formation

The Axon-Myelin Unit in Development and Degenerative Disease

Integrative Systems and Functional Analyses Reveal a Role of Dopaminergic Signaling in Myelin Pathogenesis.

Characterization of Sciatic Nerve Myelin Sheath During Development in C57BL/6 Mice

Myelination potential and injury susceptibility of grey versus white matter human oligodendrocytes

CNS myelination requires VAMP2/3-mediated membrane expansion in oligodendrocytes

Epigenetic regulation of oligodendrocyte myelination in developmental disorders and neurodegenerative diseases.

Recent progress on the molecular organization of myelinated axons

The roles of microglia and astrocytes in myelin phagocytosis in the central nervous system

CNS macrophage contributions to myelin health

Neuron to Oligodendrocyte Precursor Cell Synapses: Protagonists in Oligodendrocyte Development and Myelination, and Targets for Therapeutics

Peripheral myelin: From development to maintenance

Progress in the Studies on the Effect of Oligodendroglial Cytoskeleton in Myelination

Mechanisms of CNS myelin inhibition: Evidence for distinct and neuronal cell type specific receptor systems